NVO Novo Nordisk

FRANKFURT--The following is a summary of analysts' forecasts for Novo Nordisk A/S (NVO) third-quarter results, based on a poll of eight analysts conducted by Dow Jones Newswires (figures in million danish kroner, EPS, dividend and target price in danish kroner, according to IFRS). Earnings figures are scheduled to be released October 29.

=== 
                   Sales: 
                                                -NovoRapid/ 
3rd Quarter        -Total  -Victoza   -Levemir      NovoLog 
AVERAGE            27,006     4,588      4,639        5,289 
Prev. Year         22,249     3,441      3,728        4,471 
+/- in %              +21       +33        +24          +18 
 
MEDIAN             27,193     4,545      4,540        5,274 
Maximum            27,699     4,812      5,094        5,498 
Minimum            26,247     4,464      4,464        5,113 
Amount                  7         7          8            6 
 
Baader-Helvea      27,193     4,533      5,094           -- 
Barclays           27,198     4,812      4,510        5,260 
Exane BNP Paribas  26,681     4,535      4,619        5,113 
J.P. Morgan        26,661     4,546      4,464        5,315 
Jefferies          26,247     4,545      4,481        5,264 
Morgan Stanley     27,365     4,464      4,473        5,284 
Swedbank           27,699     4,683      4,902        5,498 
UBS                    --        --      4,570           -- 
 
 
                Operating               Net       EPS 
3rd Quarter        profit      PBT   income   diluted 
AVERAGE            11,700   10,539    8,123      3.16 
Prev. Year          8,569    8,454    6,500      2.47 
+/- in %              +37      +25      +25       +28 
 
MEDIAN             11,500   10,376    8,024      3.15 
Maximum            12,949   11,365    8,989      3.50 
Minimum            11,076    9,876    7,624      2.97 
Amount                  7        3        6         7 
 
Baader-Helvea      11,346       --    7,624      2.97 
Barclays           12,313   10,376    8,197      3.19 
Exane BNP Paribas  11,530       --    8,265      3.22 
J.P. Morgan        11,500       --       --      3.15 
Jefferies          11,076    9,876    7,812      3.04 
Morgan Stanley     11,187       --    7,850      3.05 
Swedbank           12,949   11,365    8,989      3.50 
 
 
             Target price  Rating                  DPS 2015 
AVERAGE            412.42  positive 8   AVERAGE        6.32 
Prev. Quarter      413.20  neutral  4   Prev. Year     5.00 
+/- in %             -0.2  negative 0   +/- in %        +26 
 
MEDIAN             423.50               MEDIAN         6.38 
Maximum            465.00               Maximum        6.60 
Minimum            335.00               Minimum        6.00 
Amount                 12               Amount            6 
 
Baader-Helvea      411.00  Buy                           -- 
Barclays           427.00  Overweight                  6.00 
Citi               450.00  Buy                           -- 
Commerzbank        335.00  Hold                          -- 
Exane BNP Paribas  350.00  Neutral                     6.60 
Goldman Sachs      420.00  Buy                         6.46 
J.P. Morgan        450.00  Overweight                    -- 
Jefferies          400.00  Hold                        6.54 
Kepler Cheuvreux   430.00  Buy                         6.00 
Morgan Stanley     441.00  Overweight                    -- 
Swedbank           465.00  Buy                         6.30 
UBS                370.00  Neutral                       -- 
=== 

Year-earlier figures are as reported by the company.

DJG/err 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

October 26, 2015 09:36 ET (13:36 GMT)

Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Aug 2024 to Sep 2024

Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Sep 2023 to Sep 2024